Table 3. Comparison of the laboratory parameters of the patients recorded before the extracorporeal hemadsorption.

SD: standard deviation; IL: interleukin; TNFα: tumor necrosis factor α; PCT: procalcitonin; CRP: C-reactive protein; APACHE: Acute Physiology and Chronic Health Evaluation; PMR: predicted mortality rate of the study population calculated based on APACHE score; SOFA: Sequential Organ Failure Assessment

Parameter	Survivors (n=6), mean ± SD; median (range)	Non-survivors (n=26), mean ± SD; median (range)	P-value
IL-6 (ng/L)	125.48 ± 29.55; 115.05 (95.6–174.3)	130.2 ± 43.93; 114.95 (54.3–225.8)	0.961
IL-8 (ng/L)	66.68 ± 41.32; 67.71 (20.23–120.01)	90.63 ± 61.37; 88.35 (7.87–215.4)	0.469
IL-10 (ng/L)	296.55 ± 292.33; 180.85 (58.3–856.3)	143.66 ± 148.48; 115.25 (23.15–678.1)	0.06
TNFα (pg/mL)	81.18 ± 58.25; 61.8 (33.69–196.2)	88.16 ± 48.98; 76.2 (12.45–212.2)	0.53
PCT (ng/mL)	8.22 ± 10.77; 1.81 (0.3–22.2)	6.4 ± 11.34; 2.17 (0.28–57)	0.923
CRP (mg/mL)	173.83 ± 90.48; 183.5 (63–312)	186.04 ± 66.41; 176 (100–350)	0.664
APACHE score	22 ± 7.24; 22 (13–30)	36.69 ± 8.02; 37.5 (18–50)	0.002
PMR	44.37 ± 23.94; 44.37 (16.54–70.33)	80.54 ± 16.6; 86.81 (29.13–98.01)	0.002
SOFA score	15.33 ± 0.82; 15.5 (14–16)	16.23 ± 3.39; 16 (10–24)	0.624